LISA BURGARD: Open Payments
NPI 1790723120 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,127 in 108 payments from 19 companies in 2025. Trend: 2023 $2,645 · 2024 $3,102 · 2025 $2,127
Food & beverage: $2,079Education: $48
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $357 |
| ABBVIE INC. | 17 | $285 |
| Lilly USA, LLC | 9 | $243 |
| Journey Medical Corporation | 16 | $196 |
| Galderma Laboratories, L.P. | 5 | $181 |
| Incyte Corporation | 9 | $138 |
| PFIZER INC. | 3 | $117 |
| GENZYME CORPORATION | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Arcutis Biotherapeutics, Inc. | 4 | $72 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, OPZELURA, TALTZ, EBGLYSS, LITFULO.
Industry payments across MO — which companies pay providers there.
